Latest Breaking News On - Matt scalo - Page 8 : comparemela.com

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

Myriad Genetics Announces Pricing of Upsized Offering of

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing.

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock - Myriad Genetics (NASDAQ:MYGN)

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ:MYGN) (the "Company" or "Myriad Genetics"), a leader in genetic testing and precision medicine, today announced the pricing of an upsized

Myriad Genetics Announces Proposed Offering of $100 Million

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing.